[{"id":"asa","title":"acetylsalicylic acid (ASA)","body":"<h2>Generic Name</h2>\n<p>acetylsalicylic acid (ASA)</p>\n<h2>Trade Name</h2>\n<p>Aspirin®</p>\n<h2>Classification</h2>\n<p>Platelet aggregation inhibitor, analgesic, anti-inflammatory, antipyretic</p>\n<h2>Indications</h2>\n<ul>\n<li>Acute Coronary Syndrome (ACS)</li>\n<li>Cardiac chest pain</li>\n<li>Mild pain (PCP only)</li>\n<li>Fever (PCP only)</li>\n</ul>\n<h2>Contraindications</h2>\n<ul>\n<li>Hypersensitivity to salicylates or NSAIDs</li>\n<li>Active bleed internal or external Blood clotting disorders</li>\n</ul>\n<h2>Precautions</h2>\n<p>May increase chances of Reye's syndrome in febrile pediatrics</p>\n<p>Used in caution with patients who report allergies to NSAID medications</p>\n<p>Use caution in people with active ulcers Bleeding disorders</p>\n<p>May cause bronchoconstriction in asthmatics</p>\n<p>Does higher than recommended can interfere with possible benefits</p>\n<h2>Side effects</h2>\n<ul>\n<li>Nausea/vomiting</li>\n<li>GI bleeding</li>\n<li>Heartburn</li>\n<li>Wheezing</li>\n<li>Tinnitus</li>\n<li>Hepatoxicity with large doses &gt; (1.8-3.2g daily)</li>\n</ul>\n<h2>Dose</h2>\n<p>Chest pain:</p>\n<p>Adult: 160-325mg non-enteric coated tablet chewed</p>\n<p>Pediatric: not recommended pre-hospital</p>\n<h2>Supplied</h2>\n<p>80 mg, 81 mg, 325 mg, 650 mg tablets</p>\n<h2>Mechanism</h2>\n<p>Once digested ASA causes changes to the surfaces of platelets decreasing its effectiveness in clot formation.</p>\n<p>It blocks formation of thromboxane A2, which causes platelets to aggregate and arteries to constrict in the clotting cascade. This change lasts as long as the platelet is in circulation (5 - 7 days)</p>\n<ul>\n<li>Onset in 5-30 min</li>\n<li>Peak effects within 15-120 min Duration of 1-4 hours</li>\n<li>1⁄2 life of 15-20 min</li>\n</ul>\n<h2>Notes</h2>\n<p>Should be given as soon as possible to patients with ACS indications</p>\n","meta":{"scope":"administer"},"sections":[{"title":"Generic Name","content":"acetylsalicylic acid (ASA)","content_html":"<p>acetylsalicylic acid (ASA)</p>"},{"title":"Trade Name","content":"Aspirin®","content_html":"<p>Aspirin®</p>"},{"title":"Classification","content":"Platelet aggregation inhibitor, analgesic, anti-inflammatory, antipyretic","content_html":"<p>Platelet aggregation inhibitor, analgesic, anti-inflammatory, antipyretic</p>"},{"title":"Indications","content":"- Acute Coronary Syndrome (ACS)\n- Cardiac chest pain\n- Mild pain (PCP only)\n- Fever (PCP only)","content_html":"<ul>\n<li>Acute Coronary Syndrome (ACS)</li>\n<li>Cardiac chest pain</li>\n<li>Mild pain (PCP only)</li>\n<li>Fever (PCP only)</li>\n</ul>"},{"title":"Contraindications","content":"- Hypersensitivity to salicylates or NSAIDs\n- Active bleed internal or external Blood clotting disorders","content_html":"<ul>\n<li>Hypersensitivity to salicylates or NSAIDs</li>\n<li>Active bleed internal or external Blood clotting disorders</li>\n</ul>"},{"title":"Precautions","content":"May increase chances of Reye's syndrome in febrile pediatrics\n\nUsed in caution with patients who report allergies to NSAID medications\n\nUse caution in people with active ulcers Bleeding disorders\n\nMay cause bronchoconstriction in asthmatics\n\nDoes higher than recommended can interfere with possible benefits","content_html":"<p>May increase chances of Reye's syndrome in febrile pediatrics</p>\n<p>Used in caution with patients who report allergies to NSAID medications</p>\n<p>Use caution in people with active ulcers Bleeding disorders</p>\n<p>May cause bronchoconstriction in asthmatics</p>\n<p>Does higher than recommended can interfere with possible benefits</p>"},{"title":"Side effects","content":"- Nausea/vomiting\n- GI bleeding\n- Heartburn\n- Wheezing\n- Tinnitus\n- Hepatoxicity with large doses > (1.8-3.2g daily)","content_html":"<ul>\n<li>Nausea/vomiting</li>\n<li>GI bleeding</li>\n<li>Heartburn</li>\n<li>Wheezing</li>\n<li>Tinnitus</li>\n<li>Hepatoxicity with large doses &gt; (1.8-3.2g daily)</li>\n</ul>"},{"title":"Dose","content":"Chest pain:\n\nAdult: 160-325mg non-enteric coated tablet chewed\n\nPediatric: not recommended pre-hospital","content_html":"<p>Chest pain:</p>\n<p>Adult: 160-325mg non-enteric coated tablet chewed</p>\n<p>Pediatric: not recommended pre-hospital</p>"},{"title":"Supplied","content":"80 mg, 81 mg, 325 mg, 650 mg tablets","content_html":"<p>80 mg, 81 mg, 325 mg, 650 mg tablets</p>"},{"title":"Mechanism","content":"Once digested ASA causes changes to the surfaces of platelets decreasing its effectiveness in clot formation.\n\nIt blocks formation of thromboxane A2, which causes platelets to aggregate and arteries to constrict in the clotting cascade. This change lasts as long as the platelet is in circulation (5 - 7 days)\n\n- Onset in 5-30 min\n- Peak effects within 15-120 min Duration of 1-4 hours\n- 1⁄2 life of 15-20 min","content_html":"<p>Once digested ASA causes changes to the surfaces of platelets decreasing its effectiveness in clot formation.</p>\n<p>It blocks formation of thromboxane A2, which causes platelets to aggregate and arteries to constrict in the clotting cascade. This change lasts as long as the platelet is in circulation (5 - 7 days)</p>\n<ul>\n<li>Onset in 5-30 min</li>\n<li>Peak effects within 15-120 min Duration of 1-4 hours</li>\n<li>1⁄2 life of 15-20 min</li>\n</ul>"},{"title":"Notes","content":"Should be given as soon as possible to patients with ACS indications","content_html":"<p>Should be given as soon as possible to patients with ACS indications</p>"}]},{"id":"epi","title":"epinephrine 1:1,000","body":"<h2>Generic Name</h2>\n<p>epinephrine 1:1,000</p>\n<h2>Trade Name</h2>\n<p>Adrenalin</p>\n<h2>Classification</h2>\n<p>Platelet aggregation inhibitor, analgesic, anti-inflammatory, antipyretic</p>\n<h2>Indications</h2>\n<ul>\n<li>Severe anaphylaxis</li>\n<li>Status asthmatics (ALS only)</li>\n<li>Severe reactive airway disease (ALS only)</li>\n</ul>\n<h2>Contraindications</h2>\n<ul>\n<li>None in an emergency situation</li>\n<li>Hypovolemic shock</li>\n</ul>\n<h2>Precautions</h2>\n<ul>\n<li>Epiglottitis</li>\n<li>Should be protected from light</li>\n</ul>\n<h2>Side effects</h2>\n<ul>\n<li>Palpitations</li>\n<li>Chest pain or discomfort</li>\n<li>Anxiety</li>\n<li>Hypertension</li>\n<li>Dyspnea</li>\n<li>Tremors</li>\n<li>Headache</li>\n<li>Dizziness</li>\n<li>Nausea/vomiting</li>\n<li>Increased myocardial oxygen demand</li>\n</ul>\n<h2>Dose</h2>\n<p>Anaphylaxis:</p>\n<p>Adult: (patient assist) 0.3-0.5mg IM/SQ q(10-15)</p>\n<p>Pediatric: (patient assist) Epi Jr - 0.15 mg</p>\n<h2>Supplied</h2>\n<p>1mg in 1mL ampule\nAutoinjector:</p>\n<ul>\n<li>EpiPen 0.3 mg,</li>\n<li>EpiPen JR. -0.15mg 30 mg in 30 ml multi-dose</li>\n</ul>\n<h2>Mechanism</h2>\n<p>Epinephrine works by binding to a and ß adrenergic receptors causing a stimulant response.</p>\n<p>The most prominent actions are on the beta receptors of the heart, vascular and other smooth muscle.</p>\n<p>Epinephrine relaxes the smooth muscles of the bronchi and is a physiologic antagonist of histamine, therefore reversing Histamine's effects, 20% a and 80%</p>\n<p>Rapid IV injection produces a rapid rise in blood pressure, mainly systolic by direct stimulation of the cardiac müscle which increases the ventricular contraction. (ALS only)</p>\n<p>Increased systemic vascular resistance</p>\n<ul>\n<li>\n<p>Chronotropic effeacts i c a l\n+Inotropic\n+Dromotropic effects, stociates</p>\n</li>\n<li>\n<p>Onset in 3 - 10 min SQ/IM</p>\n</li>\n<li>\n<p>Peak effects within 20 min SQ/IM</p>\n</li>\n<li>\n<p>Duration of 20 - 30 min SQ/IM</p>\n</li>\n<li>\n<p>1⁄2 life of 3- 5 min depending on rate of vasoconstriction which could delay the absorption rate</p>\n</li>\n</ul>\n<h2>Notes</h2>\n<p>Monitor vitals continually</p>\n","meta":{"scope":"assist"},"sections":[{"title":"Generic Name","content":"epinephrine 1:1,000","content_html":"<p>epinephrine 1:1,000</p>"},{"title":"Trade Name","content":"Adrenalin","content_html":"<p>Adrenalin</p>"},{"title":"Classification","content":"Platelet aggregation inhibitor, analgesic, anti-inflammatory, antipyretic","content_html":"<p>Platelet aggregation inhibitor, analgesic, anti-inflammatory, antipyretic</p>"},{"title":"Indications","content":"- Severe anaphylaxis\n- Status asthmatics (ALS only)\n- Severe reactive airway disease (ALS only)","content_html":"<ul>\n<li>Severe anaphylaxis</li>\n<li>Status asthmatics (ALS only)</li>\n<li>Severe reactive airway disease (ALS only)</li>\n</ul>"},{"title":"Contraindications","content":"- None in an emergency situation\n- Hypovolemic shock","content_html":"<ul>\n<li>None in an emergency situation</li>\n<li>Hypovolemic shock</li>\n</ul>"},{"title":"Precautions","content":"- Epiglottitis\n- Should be protected from light","content_html":"<ul>\n<li>Epiglottitis</li>\n<li>Should be protected from light</li>\n</ul>"},{"title":"Side effects","content":"- Palpitations\n- Chest pain or discomfort\n- Anxiety\n- Hypertension\n- Dyspnea\n- Tremors\n- Headache\n- Dizziness\n- Nausea/vomiting\n- Increased myocardial oxygen demand","content_html":"<ul>\n<li>Palpitations</li>\n<li>Chest pain or discomfort</li>\n<li>Anxiety</li>\n<li>Hypertension</li>\n<li>Dyspnea</li>\n<li>Tremors</li>\n<li>Headache</li>\n<li>Dizziness</li>\n<li>Nausea/vomiting</li>\n<li>Increased myocardial oxygen demand</li>\n</ul>"},{"title":"Dose","content":"Anaphylaxis:\n\nAdult: (patient assist) 0.3-0.5mg IM/SQ q(10-15)\n\nPediatric: (patient assist) Epi Jr - 0.15 mg","content_html":"<p>Anaphylaxis:</p>\n<p>Adult: (patient assist) 0.3-0.5mg IM/SQ q(10-15)</p>\n<p>Pediatric: (patient assist) Epi Jr - 0.15 mg</p>"},{"title":"Supplied","content":"1mg in 1mL ampule\nAutoinjector:\n\n- EpiPen 0.3 mg,\n- EpiPen JR. -0.15mg 30 mg in 30 ml multi-dose","content_html":"<p>1mg in 1mL ampule\nAutoinjector:</p>\n<ul>\n<li>EpiPen 0.3 mg,</li>\n<li>EpiPen JR. -0.15mg 30 mg in 30 ml multi-dose</li>\n</ul>"},{"title":"Mechanism","content":"Epinephrine works by binding to a and ß adrenergic receptors causing a stimulant response.\n\nThe most prominent actions are on the beta receptors of the heart, vascular and other smooth muscle.\n\nEpinephrine relaxes the smooth muscles of the bronchi and is a physiologic antagonist of histamine, therefore reversing Histamine's effects, 20% a and 80%\n\nRapid IV injection produces a rapid rise in blood pressure, mainly systolic by direct stimulation of the cardiac müscle which increases the ventricular contraction. (ALS only)\n\nIncreased systemic vascular resistance\n\n- Chronotropic effeacts i c a l\n  +Inotropic\n  +Dromotropic effects, stociates\n\n- Onset in 3 - 10 min SQ/IM\n- Peak effects within 20 min SQ/IM\n- Duration of 20 - 30 min SQ/IM\n- 1⁄2 life of 3- 5 min depending on rate of vasoconstriction which could delay the absorption rate","content_html":"<p>Epinephrine works by binding to a and ß adrenergic receptors causing a stimulant response.</p>\n<p>The most prominent actions are on the beta receptors of the heart, vascular and other smooth muscle.</p>\n<p>Epinephrine relaxes the smooth muscles of the bronchi and is a physiologic antagonist of histamine, therefore reversing Histamine's effects, 20% a and 80%</p>\n<p>Rapid IV injection produces a rapid rise in blood pressure, mainly systolic by direct stimulation of the cardiac müscle which increases the ventricular contraction. (ALS only)</p>\n<p>Increased systemic vascular resistance</p>\n<ul>\n<li>\n<p>Chronotropic effeacts i c a l\n+Inotropic\n+Dromotropic effects, stociates</p>\n</li>\n<li>\n<p>Onset in 3 - 10 min SQ/IM</p>\n</li>\n<li>\n<p>Peak effects within 20 min SQ/IM</p>\n</li>\n<li>\n<p>Duration of 20 - 30 min SQ/IM</p>\n</li>\n<li>\n<p>1⁄2 life of 3- 5 min depending on rate of vasoconstriction which could delay the absorption rate</p>\n</li>\n</ul>"},{"title":"Notes","content":"Monitor vitals continually","content_html":"<p>Monitor vitals continually</p>"}]},{"id":"glucagon","title":"glucagon","body":"<h2>Generic Name</h2>\n<p>glucagon</p>\n<h2>Trade Name</h2>\n<p>Glucagon</p>\n<h2>Classification</h2>\n<p>Pancreatic hormone, anti-hypoglycemic</p>\n<h2>Indications</h2>\n<p>Hypoglycemia - unable to use oral glucose</p>\n<h2>Contraindications</h2>\n<ul>\n<li>Hypersensitivity</li>\n<li>Allergy to beef or pork products</li>\n</ul>\n<h2>Precautions</h2>\n<p>May take up to 15 mins to see effects</p>\n<h2>Side effects</h2>\n<ul>\n<li>Hypotension</li>\n<li>Tachycardia</li>\n<li>Hyperglycema</li>\n<li>Nausea/vomiting</li>\n<li>Dizziness</li>\n<li>Urticaria</li>\n</ul>\n<h2>Dose</h2>\n<p>Adult: 1mg IM/SC q(7-10)</p>\n<p>Pediatric &gt; 20lg 0.5-1.0mg SC</p>\n<h2>Supplied</h2>\n<p>1mg powder with 1mL solute (needs to be reconstituted)</p>\n<h2>Mechanism</h2>\n<p>Glucagon is a naturally occurring hormone released by the pancreas\nWhen released it enters the liver causing a breakdown of glycogen stores into glucose.\nIt also inhibits the synthesis of glucose into glycogen.\nGlucagon binds to receptors on the cells membrane causing an increase of cyclic AMP (cAMP).\nThe increase in cAMP helps to facilitate calcium into the cells causing increased heart rate and inotropic response and decreases renal vascular resistance.</p>\n<p>Out of scope for FMR practitioners in Alberta.</p>\n<ul>\n<li>Onset in 1 min</li>\n<li>Peak effects are variable based on patient's condition</li>\n<li>Duration of 60 - 90 min</li>\n<li>½ life of 8 - 18 min</li>\n</ul>\n<h2>Notes</h2>\n<p>Patients must have adequate glycogen stores in the liver</p>\n<p>May have decreased to no effect on malnourished individuals</p>\n<p>Avoid shaking after reconstitution as the medication will foam and delay administration time</p>\n<p>Glucagon should not be considered as a first-line treatment for hyperglycemia</p>\n","meta":{"scope":"information-only"},"sections":[{"title":"Generic Name","content":"glucagon","content_html":"<p>glucagon</p>"},{"title":"Trade Name","content":"Glucagon","content_html":"<p>Glucagon</p>"},{"title":"Classification","content":"Pancreatic hormone, anti-hypoglycemic","content_html":"<p>Pancreatic hormone, anti-hypoglycemic</p>"},{"title":"Indications","content":"Hypoglycemia - unable to use oral glucose","content_html":"<p>Hypoglycemia - unable to use oral glucose</p>"},{"title":"Contraindications","content":"- Hypersensitivity\n- Allergy to beef or pork products","content_html":"<ul>\n<li>Hypersensitivity</li>\n<li>Allergy to beef or pork products</li>\n</ul>"},{"title":"Precautions","content":"May take up to 15 mins to see effects","content_html":"<p>May take up to 15 mins to see effects</p>"},{"title":"Side effects","content":"- Hypotension\n- Tachycardia\n- Hyperglycema\n- Nausea/vomiting\n- Dizziness\n- Urticaria","content_html":"<ul>\n<li>Hypotension</li>\n<li>Tachycardia</li>\n<li>Hyperglycema</li>\n<li>Nausea/vomiting</li>\n<li>Dizziness</li>\n<li>Urticaria</li>\n</ul>"},{"title":"Dose","content":"Adult: 1mg IM/SC q(7-10)\n\nPediatric > 20lg 0.5-1.0mg SC","content_html":"<p>Adult: 1mg IM/SC q(7-10)</p>\n<p>Pediatric &gt; 20lg 0.5-1.0mg SC</p>"},{"title":"Supplied","content":"1mg powder with 1mL solute (needs to be reconstituted)","content_html":"<p>1mg powder with 1mL solute (needs to be reconstituted)</p>"},{"title":"Mechanism","content":"Glucagon is a naturally occurring hormone released by the pancreas\nWhen released it enters the liver causing a breakdown of glycogen stores into glucose.\nIt also inhibits the synthesis of glucose into glycogen.\nGlucagon binds to receptors on the cells membrane causing an increase of cyclic AMP (cAMP).\nThe increase in cAMP helps to facilitate calcium into the cells causing increased heart rate and inotropic response and decreases renal vascular resistance.\n\nOut of scope for FMR practitioners in Alberta.\n\n- Onset in 1 min\n- Peak effects are variable based on patient's condition\n- Duration of 60 - 90 min\n- ½ life of 8 - 18 min","content_html":"<p>Glucagon is a naturally occurring hormone released by the pancreas\nWhen released it enters the liver causing a breakdown of glycogen stores into glucose.\nIt also inhibits the synthesis of glucose into glycogen.\nGlucagon binds to receptors on the cells membrane causing an increase of cyclic AMP (cAMP).\nThe increase in cAMP helps to facilitate calcium into the cells causing increased heart rate and inotropic response and decreases renal vascular resistance.</p>\n<p>Out of scope for FMR practitioners in Alberta.</p>\n<ul>\n<li>Onset in 1 min</li>\n<li>Peak effects are variable based on patient's condition</li>\n<li>Duration of 60 - 90 min</li>\n<li>½ life of 8 - 18 min</li>\n</ul>"},{"title":"Notes","content":"Patients must have adequate glycogen stores in the liver\n\nMay have decreased to no effect on malnourished individuals\n\nAvoid shaking after reconstitution as the medication will foam and delay administration time\n\nGlucagon should not be considered as a first-line treatment for hyperglycemia","content_html":"<p>Patients must have adequate glycogen stores in the liver</p>\n<p>May have decreased to no effect on malnourished individuals</p>\n<p>Avoid shaking after reconstitution as the medication will foam and delay administration time</p>\n<p>Glucagon should not be considered as a first-line treatment for hyperglycemia</p>"}]},{"id":"ib","title":"ipratropium bromide","body":"<h2>Generic Name</h2>\n<p>ipratropium bromide</p>\n<h2>Trade Name</h2>\n<p>Atrovent</p>\n<h2>Classification</h2>\n<p>Bronchodilator, anticholinergic</p>\n<h2>Indications</h2>\n<ul>\n<li>Bronchospasm associated with chronic bronchitis and emphysema</li>\n<li>Bronchospasm associated with asthma</li>\n<li>COPD exacerbation</li>\n</ul>\n<h2>Contraindications</h2>\n<ul>\n<li>Hypersensitivity to atropine, soybean protein or peanuts</li>\n<li>Closed angle glaucoma</li>\n<li>Bladder neck obstruction</li>\n<li>Prostatic hypertrophy</li>\n<li>Hypersensitivity to the drug</li>\n</ul>\n<h2>Precautions</h2>\n<p>Avoid getting in the eyes of patients especially those with glaucoma as it may lead to an increase in intra-ocular pressure by as much as 23% through muscles in your eyes relaxing</p>\n<h2>Side effects</h2>\n<ul>\n<li>Palpitations</li>\n<li>Anxiety</li>\n<li>Dizziness</li>\n<li>Headache</li>\n<li>Nausea/vomiting</li>\n<li>Coughing</li>\n<li>Dry mouth</li>\n<li>Urinary retention</li>\n</ul>\n<h2>Dose</h2>\n<p>Adult (patient assist): 4-8 puffs (80-160mcg) w/spacer q(5-10) m(30 puffs)</p>\n<h2>Supplied</h2>\n<ul>\n<li>50 mcg in 1ml</li>\n<li>20 mcg per metered dose in MDI</li>\n</ul>\n<h2>Mechanism</h2>\n<p>Ipratropium is an anticholinergic which acts by blocking acetylcholine receptors, thus inhibiting parasympathetic stimulation.</p>\n<p>This causes bronchodilation and dries respiratory tract secretions.</p>\n<ul>\n<li>Onset varies - usually &gt; 5 minutes</li>\n<li>Peak effects within 1.5 - 2 hours</li>\n<li>Duration of 4 - 6 hours</li>\n<li>1⁄2 life of 1.5 - 2 hours</li>\n</ul>\n<h2>Notes</h2>\n<p>Always administer with Ventolin because the onset of effects of Atrovent is greater than 5 min</p>\n","meta":{"scope":"assist"},"sections":[{"title":"Generic Name","content":"ipratropium bromide","content_html":"<p>ipratropium bromide</p>"},{"title":"Trade Name","content":"Atrovent","content_html":"<p>Atrovent</p>"},{"title":"Classification","content":"Bronchodilator, anticholinergic","content_html":"<p>Bronchodilator, anticholinergic</p>"},{"title":"Indications","content":"- Bronchospasm associated with chronic bronchitis and emphysema\n- Bronchospasm associated with asthma\n- COPD exacerbation","content_html":"<ul>\n<li>Bronchospasm associated with chronic bronchitis and emphysema</li>\n<li>Bronchospasm associated with asthma</li>\n<li>COPD exacerbation</li>\n</ul>"},{"title":"Contraindications","content":"- Hypersensitivity to atropine, soybean protein or peanuts\n- Closed angle glaucoma\n- Bladder neck obstruction\n- Prostatic hypertrophy\n- Hypersensitivity to the drug","content_html":"<ul>\n<li>Hypersensitivity to atropine, soybean protein or peanuts</li>\n<li>Closed angle glaucoma</li>\n<li>Bladder neck obstruction</li>\n<li>Prostatic hypertrophy</li>\n<li>Hypersensitivity to the drug</li>\n</ul>"},{"title":"Precautions","content":"Avoid getting in the eyes of patients especially those with glaucoma as it may lead to an increase in intra-ocular pressure by as much as 23% through muscles in your eyes relaxing","content_html":"<p>Avoid getting in the eyes of patients especially those with glaucoma as it may lead to an increase in intra-ocular pressure by as much as 23% through muscles in your eyes relaxing</p>"},{"title":"Side effects","content":"- Palpitations\n- Anxiety\n- Dizziness\n- Headache\n- Nausea/vomiting\n- Coughing\n- Dry mouth\n- Urinary retention","content_html":"<ul>\n<li>Palpitations</li>\n<li>Anxiety</li>\n<li>Dizziness</li>\n<li>Headache</li>\n<li>Nausea/vomiting</li>\n<li>Coughing</li>\n<li>Dry mouth</li>\n<li>Urinary retention</li>\n</ul>"},{"title":"Dose","content":"Adult (patient assist): 4-8 puffs (80-160mcg) w/spacer q(5-10) m(30 puffs)","content_html":"<p>Adult (patient assist): 4-8 puffs (80-160mcg) w/spacer q(5-10) m(30 puffs)</p>"},{"title":"Supplied","content":"- 50 mcg in 1ml\n- 20 mcg per metered dose in MDI","content_html":"<ul>\n<li>50 mcg in 1ml</li>\n<li>20 mcg per metered dose in MDI</li>\n</ul>"},{"title":"Mechanism","content":"Ipratropium is an anticholinergic which acts by blocking acetylcholine receptors, thus inhibiting parasympathetic stimulation.\n\nThis causes bronchodilation and dries respiratory tract secretions.\n\n- Onset varies - usually > 5 minutes\n- Peak effects within 1.5 - 2 hours\n- Duration of 4 - 6 hours\n- 1⁄2 life of 1.5 - 2 hours","content_html":"<p>Ipratropium is an anticholinergic which acts by blocking acetylcholine receptors, thus inhibiting parasympathetic stimulation.</p>\n<p>This causes bronchodilation and dries respiratory tract secretions.</p>\n<ul>\n<li>Onset varies - usually &gt; 5 minutes</li>\n<li>Peak effects within 1.5 - 2 hours</li>\n<li>Duration of 4 - 6 hours</li>\n<li>1⁄2 life of 1.5 - 2 hours</li>\n</ul>"},{"title":"Notes","content":"Always administer with Ventolin because the onset of effects of Atrovent is greater than 5 min","content_html":"<p>Always administer with Ventolin because the onset of effects of Atrovent is greater than 5 min</p>"}]},{"id":"naloxone","title":"naloxone","body":"<h2>Generic Name</h2>\n<p>naloxone</p>\n<h2>Trade Name</h2>\n<p>Narcan</p>\n<h2>Classification</h2>\n<p>Opioid antagonist</p>\n<h2>Indications</h2>\n<p>Complete or partial reversal of CNS and respiratory depression induced by opioids</p>\n<h2>Contraindications</h2>\n<p>Hypersensitivity</p>\n<h2>Precautions</h2>\n<p>Use with caution in narcotic-dependent patients who may experience withdrawal syndrome (including neonates for narcotic-dependent mothers)</p>\n<h2>Side Effects</h2>\n<ul>\n<li>Narcotic withdrawal syndrome</li>\n<li>Nausea/vomiting</li>\n<li>Cardiac dysrhythmias</li>\n<li>Hypotension</li>\n<li>Hypertension</li>\n</ul>\n<h2>Dose</h2>\n<p>Titrate to effect:</p>\n<ul>\n<li>Adult IM: 0.4mg m(2mg)</li>\n<li>Adult IN: 1.0mg/nare, q(3-5) prn</li>\n<li>Pediatric: 0.1mg/kg given MI m(2mg)</li>\n</ul>\n<h2>Supplied</h2>\n<p>2 mg in 2 mL vials</p>\n<h2>Mechanism</h2>\n<p>Naloxone is a competitive narcotic antagonist.</p>\n<p>It competes for narcotic receptors in the brain and it can also displace narcotic molecules from the receptors.</p>\n<p>It can be used to treat narcotics and synthetic narcotic agents.</p>\n<ul>\n<li>Onset in &lt; 2min IV/10, 2-10 min IM/ETT (ETT ALS only)</li>\n<li>Peak effects within &lt; 2min IV/lO, 2-10 min IM/ETT (ETT ALS only)</li>\n<li>Duration of 20-120 min</li>\n<li>1⁄2 life of 60-90min</li>\n</ul>\n<h2>Notes</h2>\n<p>Higher doses of 10 -20 mg may be required for overdoses of synthetic narcotics. Narcan has no real effect when given when narcotics are not present.</p>\n<p>Should be used ni caution ni the case of polypharmacy overdoses, though respiratory depression usually the largest issue for administration.</p>\n","meta":{"scope":"administer"},"sections":[{"title":"Generic Name","content":"naloxone","content_html":"<p>naloxone</p>"},{"title":"Trade Name","content":"Narcan","content_html":"<p>Narcan</p>"},{"title":"Classification","content":"Opioid antagonist","content_html":"<p>Opioid antagonist</p>"},{"title":"Indications","content":"Complete or partial reversal of CNS and respiratory depression induced by opioids","content_html":"<p>Complete or partial reversal of CNS and respiratory depression induced by opioids</p>"},{"title":"Contraindications","content":"Hypersensitivity","content_html":"<p>Hypersensitivity</p>"},{"title":"Precautions","content":"Use with caution in narcotic-dependent patients who may experience withdrawal syndrome (including neonates for narcotic-dependent mothers)","content_html":"<p>Use with caution in narcotic-dependent patients who may experience withdrawal syndrome (including neonates for narcotic-dependent mothers)</p>"},{"title":"Side Effects","content":"- Narcotic withdrawal syndrome\n- Nausea/vomiting\n- Cardiac dysrhythmias\n- Hypotension\n- Hypertension","content_html":"<ul>\n<li>Narcotic withdrawal syndrome</li>\n<li>Nausea/vomiting</li>\n<li>Cardiac dysrhythmias</li>\n<li>Hypotension</li>\n<li>Hypertension</li>\n</ul>"},{"title":"Dose","content":"Titrate to effect:\n\n- Adult IM: 0.4mg m(2mg)\n- Adult IN: 1.0mg/nare, q(3-5) prn\n- Pediatric: 0.1mg/kg given MI m(2mg)","content_html":"<p>Titrate to effect:</p>\n<ul>\n<li>Adult IM: 0.4mg m(2mg)</li>\n<li>Adult IN: 1.0mg/nare, q(3-5) prn</li>\n<li>Pediatric: 0.1mg/kg given MI m(2mg)</li>\n</ul>"},{"title":"Supplied","content":"2 mg in 2 mL vials","content_html":"<p>2 mg in 2 mL vials</p>"},{"title":"Mechanism","content":"Naloxone is a competitive narcotic antagonist.\n\nIt competes for narcotic receptors in the brain and it can also displace narcotic molecules from the receptors.\n\nIt can be used to treat narcotics and synthetic narcotic agents.\n\n- Onset in < 2min IV/10, 2-10 min IM/ETT (ETT ALS only)\n- Peak effects within < 2min IV/lO, 2-10 min IM/ETT (ETT ALS only)\n- Duration of 20-120 min\n- 1⁄2 life of 60-90min","content_html":"<p>Naloxone is a competitive narcotic antagonist.</p>\n<p>It competes for narcotic receptors in the brain and it can also displace narcotic molecules from the receptors.</p>\n<p>It can be used to treat narcotics and synthetic narcotic agents.</p>\n<ul>\n<li>Onset in &lt; 2min IV/10, 2-10 min IM/ETT (ETT ALS only)</li>\n<li>Peak effects within &lt; 2min IV/lO, 2-10 min IM/ETT (ETT ALS only)</li>\n<li>Duration of 20-120 min</li>\n<li>1⁄2 life of 60-90min</li>\n</ul>"},{"title":"Notes","content":"Higher doses of 10 -20 mg may be required for overdoses of synthetic narcotics. Narcan has no real effect when given when narcotics are not present.\n\nShould be used ni caution ni the case of polypharmacy overdoses, though respiratory depression usually the largest issue for administration.","content_html":"<p>Higher doses of 10 -20 mg may be required for overdoses of synthetic narcotics. Narcan has no real effect when given when narcotics are not present.</p>\n<p>Should be used ni caution ni the case of polypharmacy overdoses, though respiratory depression usually the largest issue for administration.</p>"}]},{"id":"nitroglycerine","title":"nitroglycerin","body":"<h2>Generic Name</h2>\n<p>nitroglycerin</p>\n<h2>Trade</h2>\n<p>Nitrolingual (spray), Nitrostat (tablets)</p>\n<h2>Indications</h2>\n<ul>\n<li>Ischemic chest pain</li>\n<li>Acute congestive heart failure (CHF)</li>\n<li>Acute coronary syndrome (ACS)</li>\n<li>Angina pectoris</li>\n</ul>\n<h2>Contraindications</h2>\n<ul>\n<li>Hypersensitivity</li>\n<li>Blood pressure below 100 systolic (RVI 100) or &gt;30mmHg below baseline</li>\n<li>Viagra (sildenafil) or Levitra (vardenafil) use in the past 24 hours</li>\n<li>Cialis (tedalafil) use within the past 48 hours</li>\n<li>Cerebral haemorrhage</li>\n<li>Extremy bradycardia or tachycardia (&lt;50 BPM or &gt;100BPM in the absense of heart failure)</li>\n</ul>\n<h2>Precautions</h2>\n<p>Patients taking nitroglycerin regularly may develop a tolerance for the drug</p>\n<p>Use extreme caution in RVI patients (preload dependant)</p>\n<p>Unable to initiate an IV</p>\n<h2>Side effects</h2>\n<ul>\n<li>Hypotension</li>\n<li>Nausea/vomiting</li>\n<li>Headache</li>\n<li>Tachycardia</li>\n<li>Dizziness</li>\n</ul>\n<h2>Dose</h2>\n<p>Adult:</p>\n<p>** Patient Assist and not currently within scope in Alberta **</p>\n<p>0.4mg spray SL q(5) until relief or BP &lt; 100 systolic or m(3 sprays in 15 min)\n0.5-0.5mg/hr patch q(1)\n0.3mg tablet SL</p>\n<h2>Supplied</h2>\n<p>0.3mg Tablet\n0.4mg Metered Dose Spray\n0.4,0.8mg/hr patches</p>\n<h2>Mechanism</h2>\n<p>Nitroglycerin is a rapid smooth muscle relaxant that causes peripheral vasodilation of blood vessels and decreases return to the heart (preload), to a lesser extent on the afterload.</p>\n<p>This decreases the workload of the cardiac muscle, hence decreasing myocardial oxygen demand and as a result improves the perfusion to the ischemic myocardium</p>\n<p>Nitroglycerin is lipid soluble and is thought to enter the body from the GI tract through the lymphatics rather than the portal blood</p>\n<ul>\n<li>Onset in 1-2 min</li>\n<li>Peak effect within 5-10 min</li>\n<li>Duration of 20-30 min</li>\n<li>½ life of 1-5 min</li>\n</ul>\n<h2>Notes</h2>\n<p>Remove patches before administering dose</p>\n<p>Nitro should be kept from direct light and in glass containers</p>\n<p>Remove all patches in cardiac arrest situations</p>\n<p>Administer IV nitroglycerin by infusion pump to ensure precise flow rate</p>\n","meta":{"scope":"information-only"},"sections":[{"title":"Generic Name","content":"nitroglycerin","content_html":"<p>nitroglycerin</p>"},{"title":"Trade","content":"Nitrolingual (spray), Nitrostat (tablets)","content_html":"<p>Nitrolingual (spray), Nitrostat (tablets)</p>"},{"title":"Indications","content":"- Ischemic chest pain\n- Acute congestive heart failure (CHF)\n- Acute coronary syndrome (ACS)\n- Angina pectoris","content_html":"<ul>\n<li>Ischemic chest pain</li>\n<li>Acute congestive heart failure (CHF)</li>\n<li>Acute coronary syndrome (ACS)</li>\n<li>Angina pectoris</li>\n</ul>"},{"title":"Contraindications","content":"- Hypersensitivity\n- Blood pressure below 100 systolic (RVI 100) or >30mmHg below baseline\n- Viagra (sildenafil) or Levitra (vardenafil) use in the past 24 hours\n- Cialis (tedalafil) use within the past 48 hours\n- Cerebral haemorrhage\n- Extremy bradycardia or tachycardia (<50 BPM or >100BPM in the absense of heart failure)","content_html":"<ul>\n<li>Hypersensitivity</li>\n<li>Blood pressure below 100 systolic (RVI 100) or &gt;30mmHg below baseline</li>\n<li>Viagra (sildenafil) or Levitra (vardenafil) use in the past 24 hours</li>\n<li>Cialis (tedalafil) use within the past 48 hours</li>\n<li>Cerebral haemorrhage</li>\n<li>Extremy bradycardia or tachycardia (&lt;50 BPM or &gt;100BPM in the absense of heart failure)</li>\n</ul>"},{"title":"Precautions","content":"Patients taking nitroglycerin regularly may develop a tolerance for the drug\n\nUse extreme caution in RVI patients (preload dependant)\n\nUnable to initiate an IV","content_html":"<p>Patients taking nitroglycerin regularly may develop a tolerance for the drug</p>\n<p>Use extreme caution in RVI patients (preload dependant)</p>\n<p>Unable to initiate an IV</p>"},{"title":"Side effects","content":"- Hypotension\n- Nausea/vomiting\n- Headache\n- Tachycardia\n- Dizziness","content_html":"<ul>\n<li>Hypotension</li>\n<li>Nausea/vomiting</li>\n<li>Headache</li>\n<li>Tachycardia</li>\n<li>Dizziness</li>\n</ul>"},{"title":"Dose","content":"Adult:\n\n** Patient Assist and not currently within scope in Alberta **\n\n0.4mg spray SL q(5) until relief or BP < 100 systolic or m(3 sprays in 15 min)\n0.5-0.5mg/hr patch q(1)\n0.3mg tablet SL","content_html":"<p>Adult:</p>\n<p>** Patient Assist and not currently within scope in Alberta **</p>\n<p>0.4mg spray SL q(5) until relief or BP &lt; 100 systolic or m(3 sprays in 15 min)\n0.5-0.5mg/hr patch q(1)\n0.3mg tablet SL</p>"},{"title":"Supplied","content":"0.3mg Tablet\n0.4mg Metered Dose Spray\n0.4,0.8mg/hr patches","content_html":"<p>0.3mg Tablet\n0.4mg Metered Dose Spray\n0.4,0.8mg/hr patches</p>"},{"title":"Mechanism","content":"Nitroglycerin is a rapid smooth muscle relaxant that causes peripheral vasodilation of blood vessels and decreases return to the heart (preload), to a lesser extent on the afterload.\n\nThis decreases the workload of the cardiac muscle, hence decreasing myocardial oxygen demand and as a result improves the perfusion to the ischemic myocardium\n\nNitroglycerin is lipid soluble and is thought to enter the body from the GI tract through the lymphatics rather than the portal blood\n\n- Onset in 1-2 min\n- Peak effect within 5-10 min\n- Duration of 20-30 min\n- ½ life of 1-5 min","content_html":"<p>Nitroglycerin is a rapid smooth muscle relaxant that causes peripheral vasodilation of blood vessels and decreases return to the heart (preload), to a lesser extent on the afterload.</p>\n<p>This decreases the workload of the cardiac muscle, hence decreasing myocardial oxygen demand and as a result improves the perfusion to the ischemic myocardium</p>\n<p>Nitroglycerin is lipid soluble and is thought to enter the body from the GI tract through the lymphatics rather than the portal blood</p>\n<ul>\n<li>Onset in 1-2 min</li>\n<li>Peak effect within 5-10 min</li>\n<li>Duration of 20-30 min</li>\n<li>½ life of 1-5 min</li>\n</ul>"},{"title":"Notes","content":"Remove patches before administering dose\n\nNitro should be kept from direct light and in glass containers\n\nRemove all patches in cardiac arrest situations\n\nAdminister IV nitroglycerin by infusion pump to ensure precise flow rate","content_html":"<p>Remove patches before administering dose</p>\n<p>Nitro should be kept from direct light and in glass containers</p>\n<p>Remove all patches in cardiac arrest situations</p>\n<p>Administer IV nitroglycerin by infusion pump to ensure precise flow rate</p>"}]},{"id":"nox","title":"nitrous oxide","body":"<h2>Generic Name</h2>\n<p>nitrous oxide</p>\n<h2>Trade Name</h2>\n<p>Entonox, Nitronox</p>\n<h2>Classification</h2>\n<p>Gaseous analgesic, anesthetic gas</p>\n<h2>Indications</h2>\n<ul>\n<li>Muscular skeletal pain (particularly fractures)</li>\n<li>Back pain</li>\n<li>Ischemic chest pain</li>\n<li>Active labour -child birth</li>\n<li>Burns</li>\n</ul>\n<h2>Contraindications</h2>\n<ul>\n<li>Patient is unable to self-administer</li>\n<li>Altered LOC</li>\n<li>Head injury</li>\n<li>Intoxicated person</li>\n<li>Patient has a need for &gt; 50% oxygen</li>\n<li>Undiagnosed abdominal pain</li>\n<li>Pneumothorax</li>\n<li>COPD</li>\n<li>Bowel obstruction</li>\n<li>Nitrogen narcosis</li>\n<li>Decompression sickness</li>\n<li>Severe facial injury</li>\n</ul>\n<h2>Precautions</h2>\n<p>If the patient has been scuba diving in the last 24 hours - could cause decompression sickness</p>\n<p>Nitrous oxide may potentiate other CNS depressants such as narcotics, alcohol etc.</p>\n<h2>Side Effects</h2>\n<ul>\n<li>Dizziness</li>\n<li>Altered LOC</li>\n<li>Nausea/vomiting</li>\n<li>Hallucinations</li>\n<li>Decreased sexual inhibitions</li>\n</ul>\n<h2>Dose</h2>\n<ul>\n<li>Patients can breathe gas until relief is felt</li>\n<li>Make sure to keep mask on with a good seal to get</li>\n</ul>\n<h2>Supplied</h2>\n<p>Blue and white cylinder with demand valve mask</p>\n<h2>Mechanism</h2>\n<p>Nitrous oxide is a CNS depressant with potent analgesic and weak anesthetic properties.</p>\n<p>The effects of Entonox® take place within the CNS and are related to the release of endogenous neurotransmitters such as opioid peptides and serotonin and is responsible for the activation of certain opioid receptors.</p>\n<p>Entonox® is said to work with the gray area of the midbrain where the opioid peptides are released.</p>\n<p>Entonox® is a mixture of 50% oxygen and 50% nitrous oxide.</p>\n<ul>\n<li>Onset in 2 - 5 min</li>\n<li>Peak effects within 2 - 5 min</li>\n<li>Duration of 2 - 5 min</li>\n<li>1⁄2 life is unknown</li>\n</ul>\n<h2>Notes</h2>\n<ul>\n<li>Invert bottle at least three times to ensure gases are mixed</li>\n<li>Keep in warm area</li>\n<li>Liquids may not vaporize in cold environments</li>\n<li>Make note of psi and time at the beginning and end of use Document amount of gas used</li>\n<li>Use only in well ventilated area</li>\n</ul>\n","meta":{"scope":"assist"},"sections":[{"title":"Generic Name","content":"nitrous oxide","content_html":"<p>nitrous oxide</p>"},{"title":"Trade Name","content":"Entonox, Nitronox","content_html":"<p>Entonox, Nitronox</p>"},{"title":"Classification","content":"Gaseous analgesic, anesthetic gas","content_html":"<p>Gaseous analgesic, anesthetic gas</p>"},{"title":"Indications","content":"- Muscular skeletal pain (particularly fractures)\n- Back pain\n- Ischemic chest pain\n- Active labour -child birth\n- Burns","content_html":"<ul>\n<li>Muscular skeletal pain (particularly fractures)</li>\n<li>Back pain</li>\n<li>Ischemic chest pain</li>\n<li>Active labour -child birth</li>\n<li>Burns</li>\n</ul>"},{"title":"Contraindications","content":"- Patient is unable to self-administer\n- Altered LOC\n- Head injury\n- Intoxicated person\n- Patient has a need for > 50% oxygen\n- Undiagnosed abdominal pain\n- Pneumothorax\n- COPD\n- Bowel obstruction\n- Nitrogen narcosis\n- Decompression sickness\n- Severe facial injury","content_html":"<ul>\n<li>Patient is unable to self-administer</li>\n<li>Altered LOC</li>\n<li>Head injury</li>\n<li>Intoxicated person</li>\n<li>Patient has a need for &gt; 50% oxygen</li>\n<li>Undiagnosed abdominal pain</li>\n<li>Pneumothorax</li>\n<li>COPD</li>\n<li>Bowel obstruction</li>\n<li>Nitrogen narcosis</li>\n<li>Decompression sickness</li>\n<li>Severe facial injury</li>\n</ul>"},{"title":"Precautions","content":"If the patient has been scuba diving in the last 24 hours - could cause decompression sickness\n\nNitrous oxide may potentiate other CNS depressants such as narcotics, alcohol etc.","content_html":"<p>If the patient has been scuba diving in the last 24 hours - could cause decompression sickness</p>\n<p>Nitrous oxide may potentiate other CNS depressants such as narcotics, alcohol etc.</p>"},{"title":"Side Effects","content":"- Dizziness\n- Altered LOC\n- Nausea/vomiting\n- Hallucinations\n- Decreased sexual inhibitions","content_html":"<ul>\n<li>Dizziness</li>\n<li>Altered LOC</li>\n<li>Nausea/vomiting</li>\n<li>Hallucinations</li>\n<li>Decreased sexual inhibitions</li>\n</ul>"},{"title":"Dose","content":"- Patients can breathe gas until relief is felt\n- Make sure to keep mask on with a good seal to get","content_html":"<ul>\n<li>Patients can breathe gas until relief is felt</li>\n<li>Make sure to keep mask on with a good seal to get</li>\n</ul>"},{"title":"Supplied","content":"Blue and white cylinder with demand valve mask","content_html":"<p>Blue and white cylinder with demand valve mask</p>"},{"title":"Mechanism","content":"Nitrous oxide is a CNS depressant with potent analgesic and weak anesthetic properties.\n\nThe effects of Entonox® take place within the CNS and are related to the release of endogenous neurotransmitters such as opioid peptides and serotonin and is responsible for the activation of certain opioid receptors.\n\nEntonox® is said to work with the gray area of the midbrain where the opioid peptides are released.\n\nEntonox® is a mixture of 50% oxygen and 50% nitrous oxide.\n\n- Onset in 2 - 5 min\n- Peak effects within 2 - 5 min\n- Duration of 2 - 5 min\n- 1⁄2 life is unknown","content_html":"<p>Nitrous oxide is a CNS depressant with potent analgesic and weak anesthetic properties.</p>\n<p>The effects of Entonox® take place within the CNS and are related to the release of endogenous neurotransmitters such as opioid peptides and serotonin and is responsible for the activation of certain opioid receptors.</p>\n<p>Entonox® is said to work with the gray area of the midbrain where the opioid peptides are released.</p>\n<p>Entonox® is a mixture of 50% oxygen and 50% nitrous oxide.</p>\n<ul>\n<li>Onset in 2 - 5 min</li>\n<li>Peak effects within 2 - 5 min</li>\n<li>Duration of 2 - 5 min</li>\n<li>1⁄2 life is unknown</li>\n</ul>"},{"title":"Notes","content":"- Invert bottle at least three times to ensure gases are mixed\n- Keep in warm area\n- Liquids may not vaporize in cold environments\n- Make note of psi and time at the beginning and end of use Document amount of gas used\n- Use only in well ventilated area","content_html":"<ul>\n<li>Invert bottle at least three times to ensure gases are mixed</li>\n<li>Keep in warm area</li>\n<li>Liquids may not vaporize in cold environments</li>\n<li>Make note of psi and time at the beginning and end of use Document amount of gas used</li>\n<li>Use only in well ventilated area</li>\n</ul>"}]},{"id":"oralglucose","title":"oral glucose","body":"<h2>Generic Name</h2>\n<p>oral glucose</p>\n<h2>Trade Name</h2>\n<p>Oral glucose</p>\n<h2>Indications</h2>\n<p>Hypoglycemia</p>\n<h2>Contraindications</h2>\n<ul>\n<li>No active gag reflex</li>\n<li>Patient is unable to maintain their own airway</li>\n<li>Hyperglycemia</li>\n</ul>\n<h2>Precautions</h2>\n<p>None</p>\n<h2>Side effects</h2>\n<ul>\n<li>Nausea/vomiting</li>\n<li>Dizziness</li>\n</ul>\n<h2>Dose</h2>\n<p>24 - 31g</p>\n<h2>Supplied</h2>\n<ul>\n<li>24g dextrose in one tube</li>\n<li>6g per tablet</li>\n<li>31g per bottle of liquid</li>\n</ul>\n<h2>Mechanism</h2>\n<p>Oral glucose is a simple sugar used to rapidly increase blood sugar levels within the body.</p>\n<p>It is in a state that the body does not need to alter for use, which increases the rate of absorption.</p>\n<ul>\n<li>Onset in 1 min PO</li>\n<li>Peak effects within 3 min</li>\n<li>Duration is brief</li>\n<li>½ life is unknown</li>\n</ul>\n<h2>Notes</h2>\n<ul>\n<li>Patient must be able to self-administer drug</li>\n<li>Give patient more complex carbohydrates as glucose is quickly used up</li>\n<li>Given orally to increase sugar to &gt; 4mmol/l</li>\n<li>Mustbe swallowed to be effective</li>\n</ul>\n","meta":{"scope":"administer"},"sections":[{"title":"Generic Name","content":"oral glucose","content_html":"<p>oral glucose</p>"},{"title":"Trade Name","content":"Oral glucose","content_html":"<p>Oral glucose</p>"},{"title":"Indications","content":"Hypoglycemia","content_html":"<p>Hypoglycemia</p>"},{"title":"Contraindications","content":"- No active gag reflex\n- Patient is unable to maintain their own airway\n- Hyperglycemia","content_html":"<ul>\n<li>No active gag reflex</li>\n<li>Patient is unable to maintain their own airway</li>\n<li>Hyperglycemia</li>\n</ul>"},{"title":"Precautions","content":"None","content_html":"<p>None</p>"},{"title":"Side effects","content":"- Nausea/vomiting\n- Dizziness","content_html":"<ul>\n<li>Nausea/vomiting</li>\n<li>Dizziness</li>\n</ul>"},{"title":"Dose","content":"24 - 31g","content_html":"<p>24 - 31g</p>"},{"title":"Supplied","content":"- 24g dextrose in one tube\n- 6g per tablet\n- 31g per bottle of liquid","content_html":"<ul>\n<li>24g dextrose in one tube</li>\n<li>6g per tablet</li>\n<li>31g per bottle of liquid</li>\n</ul>"},{"title":"Mechanism","content":"Oral glucose is a simple sugar used to rapidly increase blood sugar levels within the body.\n\nIt is in a state that the body does not need to alter for use, which increases the rate of absorption.\n\n- Onset in 1 min PO\n- Peak effects within 3 min\n- Duration is brief\n- ½ life is unknown","content_html":"<p>Oral glucose is a simple sugar used to rapidly increase blood sugar levels within the body.</p>\n<p>It is in a state that the body does not need to alter for use, which increases the rate of absorption.</p>\n<ul>\n<li>Onset in 1 min PO</li>\n<li>Peak effects within 3 min</li>\n<li>Duration is brief</li>\n<li>½ life is unknown</li>\n</ul>"},{"title":"Notes","content":"- Patient must be able to self-administer drug\n- Give patient more complex carbohydrates as glucose is quickly used up\n- Given orally to increase sugar to > 4mmol/l\n- Mustbe swallowed to be effective","content_html":"<ul>\n<li>Patient must be able to self-administer drug</li>\n<li>Give patient more complex carbohydrates as glucose is quickly used up</li>\n<li>Given orally to increase sugar to &gt; 4mmol/l</li>\n<li>Mustbe swallowed to be effective</li>\n</ul>"}]},{"id":"oxygen","title":"oxygen","body":"<h2>Generic Name</h2>\n<p>oxygen</p>\n<h2>Trade Name</h2>\n<p>Oxygen</p>\n<h2>Indications</h2>\n<ul>\n<li>Hypoxia</li>\n<li>Ischemic chest pain with an SPO2 of &lt; 95%</li>\n<li>Respiratory insufficiency</li>\n<li>Confirmed or suspected CO poisoning and other causes of decreased tissue oxygenation</li>\n<li>Any critical patient</li>\n</ul>\n<h2>Contraindications</h2>\n<p>Oxygen should never be withheld in a critically ill or injured patient</p>\n<h2>Precautions</h2>\n<p>Oxygen should be used cautiously in patients with COPD</p>\n<p>In these patients, respirations are often regulated by the level of oxygen in the blood (hypoxic drive) and not CO2 levels</p>\n<p>In some cases, COPD patients may sufer severe respiratory depression if high concentrations of oxygen are delivered for extended periods of time &gt; 18 hours</p>\n<h2>Side Effects</h2>\n<p>Prolonged non-humidified high flow oxygen administration mya cause drying of the mucous membranes</p>\n<h2>Dose</h2>\n<ul>\n<li>Nasal cannula: 1 - 6L/m = 24-44%</li>\n<li>Simplefacemask: 8-10L/m = 40-60%</li>\n<li>Partial non-rebreather mask: 6-10L/m = 35-60%</li>\n<li>Non-rebreathingmask: 10-15L/m = 80-95%</li>\n<li>Bag valve mask: 12 - 20L/m = 90-100%</li>\n</ul>\n<h2>Supplied</h2>\n<p>Various commonly utilized pre-hospital cylinders:</p>\n<ul>\n<li>D tank: 400L</li>\n<li>E tank: 660L</li>\n<li>M tank: 3000L</li>\n<li>H tank: 7080L</li>\n</ul>\n<h2>Mechanism</h2>\n<p>Oxygen enters the body through the respiratory system and si transported to the cells by hemoglobin found in the red blood cells.</p>\n<p>Oxygen is required for the efficient breakdown of glucose into a useable energy form adenosine triphosphate (ATP).</p>\n<p>The administration of enriched oxygen increases the oxygen concentration in the alveoli, which subsequently increase the oxygen saturation of available hemoglobin and therefore may assist in reducing the size of infracted tissue during an acute myocardial infarction in patients who are hypoxemic on room air.</p>\n<ul>\n<li>Onset is immediate</li>\n<li>Peak effect within &lt; 1 min</li>\n<li>Duration of &lt; 2 min</li>\n<li>½ life is not applicable</li>\n</ul>\n<h2>Notes</h2>\n<p>Oxygen supports combustion vigorously so not should be used in explosive environments</p>\n","meta":{"scope":"administer"},"sections":[{"title":"Generic Name","content":"oxygen","content_html":"<p>oxygen</p>"},{"title":"Trade Name","content":"Oxygen","content_html":"<p>Oxygen</p>"},{"title":"Indications","content":"- Hypoxia\n- Ischemic chest pain with an SPO2 of < 95%\n- Respiratory insufficiency\n- Confirmed or suspected CO poisoning and other causes of decreased tissue oxygenation\n- Any critical patient","content_html":"<ul>\n<li>Hypoxia</li>\n<li>Ischemic chest pain with an SPO2 of &lt; 95%</li>\n<li>Respiratory insufficiency</li>\n<li>Confirmed or suspected CO poisoning and other causes of decreased tissue oxygenation</li>\n<li>Any critical patient</li>\n</ul>"},{"title":"Contraindications","content":"Oxygen should never be withheld in a critically ill or injured patient","content_html":"<p>Oxygen should never be withheld in a critically ill or injured patient</p>"},{"title":"Precautions","content":"Oxygen should be used cautiously in patients with COPD\n\nIn these patients, respirations are often regulated by the level of oxygen in the blood (hypoxic drive) and not CO2 levels\n\nIn some cases, COPD patients may sufer severe respiratory depression if high concentrations of oxygen are delivered for extended periods of time > 18 hours","content_html":"<p>Oxygen should be used cautiously in patients with COPD</p>\n<p>In these patients, respirations are often regulated by the level of oxygen in the blood (hypoxic drive) and not CO2 levels</p>\n<p>In some cases, COPD patients may sufer severe respiratory depression if high concentrations of oxygen are delivered for extended periods of time &gt; 18 hours</p>"},{"title":"Side Effects","content":"Prolonged non-humidified high flow oxygen administration mya cause drying of the mucous membranes","content_html":"<p>Prolonged non-humidified high flow oxygen administration mya cause drying of the mucous membranes</p>"},{"title":"Dose","content":"- Nasal cannula: 1 - 6L/m = 24-44%\n- Simplefacemask: 8-10L/m = 40-60%\n- Partial non-rebreather mask: 6-10L/m = 35-60%\n- Non-rebreathingmask: 10-15L/m = 80-95%\n- Bag valve mask: 12 - 20L/m = 90-100%","content_html":"<ul>\n<li>Nasal cannula: 1 - 6L/m = 24-44%</li>\n<li>Simplefacemask: 8-10L/m = 40-60%</li>\n<li>Partial non-rebreather mask: 6-10L/m = 35-60%</li>\n<li>Non-rebreathingmask: 10-15L/m = 80-95%</li>\n<li>Bag valve mask: 12 - 20L/m = 90-100%</li>\n</ul>"},{"title":"Supplied","content":"Various commonly utilized pre-hospital cylinders:\n\n- D tank: 400L\n- E tank: 660L\n- M tank: 3000L\n- H tank: 7080L","content_html":"<p>Various commonly utilized pre-hospital cylinders:</p>\n<ul>\n<li>D tank: 400L</li>\n<li>E tank: 660L</li>\n<li>M tank: 3000L</li>\n<li>H tank: 7080L</li>\n</ul>"},{"title":"Mechanism","content":"Oxygen enters the body through the respiratory system and si transported to the cells by hemoglobin found in the red blood cells.\n\nOxygen is required for the efficient breakdown of glucose into a useable energy form adenosine triphosphate (ATP).\n\nThe administration of enriched oxygen increases the oxygen concentration in the alveoli, which subsequently increase the oxygen saturation of available hemoglobin and therefore may assist in reducing the size of infracted tissue during an acute myocardial infarction in patients who are hypoxemic on room air.\n\n- Onset is immediate\n- Peak effect within < 1 min\n- Duration of < 2 min\n- ½ life is not applicable","content_html":"<p>Oxygen enters the body through the respiratory system and si transported to the cells by hemoglobin found in the red blood cells.</p>\n<p>Oxygen is required for the efficient breakdown of glucose into a useable energy form adenosine triphosphate (ATP).</p>\n<p>The administration of enriched oxygen increases the oxygen concentration in the alveoli, which subsequently increase the oxygen saturation of available hemoglobin and therefore may assist in reducing the size of infracted tissue during an acute myocardial infarction in patients who are hypoxemic on room air.</p>\n<ul>\n<li>Onset is immediate</li>\n<li>Peak effect within &lt; 1 min</li>\n<li>Duration of &lt; 2 min</li>\n<li>½ life is not applicable</li>\n</ul>"},{"title":"Notes","content":"Oxygen supports combustion vigorously so not should be used in explosive environments","content_html":"<p>Oxygen supports combustion vigorously so not should be used in explosive environments</p>"}]},{"id":"salbutamol","title":"salbutamol sulfate","body":"<h2>Generic Name</h2>\n<p>salbutamol sulfate</p>\n<h2>Trade Name</h2>\n<p>Ventolin (Canada), Atrovent (United States)</p>\n<h2>Classification</h2>\n<p>Bronchodilator, sympathomimetic</p>\n<h2>Indications</h2>\n<ul>\n<li>Bronchospasm</li>\n<li>Anaphylaxis</li>\n<li>Hyperkalemia (ALS only)</li>\n</ul>\n<h2>Contraindications</h2>\n<p>Hypersensitivity</p>\n<h2>Precautions</h2>\n<ul>\n<li>Cardiac arrhythmias associated with tachycardia</li>\n<li>Caution in patients with cardiac history</li>\n<li>May cause hypokalemia</li>\n<li>May cause hyperglycemia</li>\n<li>Watch for paradoxical bronchospasm (stop igit initmmediately)</li>\n</ul>\n<h2>Side effects</h2>\n<ul>\n<li>Headache</li>\n<li>Dizziness</li>\n<li>Nausea/vomiting</li>\n<li>Tremors</li>\n<li>Arrhythmias</li>\n<li>Palpitations</li>\n<li>Tachycardia</li>\n<li>Muscle cramps</li>\n</ul>\n<h2>Dose</h2>\n<p>Adult (assist): 5-10 puffs (50-10mcg) q(5-10) m(∞)</p>\n<p>Pediatric (assist): &lt; 20kg: 2- 4 puffs with MDI and spacer &gt; 20kg: 4-8 puffs wit hMDI and spacer</p>\n<h2>Supplied</h2>\n<ul>\n<li>Solution: 2.5 mg/2.5 mL NS</li>\n<li>Metered dose inhaler (MDI): 100 mcg per dose</li>\n</ul>\n<h2>Mechanism</h2>\n<p>Salbutamol sulfate is a sympathomimetic which is selective for B2-adrenergic receptors.</p>\n<p>It relaxes smooth muscles of the bronchial tree and peripheral vasculature by stimulating adrenergic receptors of the sympathetic nervous system.</p>\n<ul>\n<li>Onset in 5-8 min</li>\n<li>Peak effects within 1-1.5 hours</li>\n<li>Duration of 3-6 hours</li>\n<li>1⁄2 life of ≤ 3 hours</li>\n</ul>\n<h2>Notes</h2>\n<p>Watch for tachycardia with administration</p>\n<p>Decreased effect in patients on beta blockers</p>\n<p>Salbutamol may precipitate angina and dyshythmias</p>\n","meta":{"scope":"assist"},"sections":[{"title":"Generic Name","content":"salbutamol sulfate","content_html":"<p>salbutamol sulfate</p>"},{"title":"Trade Name","content":"Ventolin (Canada), Atrovent (United States)","content_html":"<p>Ventolin (Canada), Atrovent (United States)</p>"},{"title":"Classification","content":"Bronchodilator, sympathomimetic","content_html":"<p>Bronchodilator, sympathomimetic</p>"},{"title":"Indications","content":"- Bronchospasm\n- Anaphylaxis\n- Hyperkalemia (ALS only)","content_html":"<ul>\n<li>Bronchospasm</li>\n<li>Anaphylaxis</li>\n<li>Hyperkalemia (ALS only)</li>\n</ul>"},{"title":"Contraindications","content":"Hypersensitivity","content_html":"<p>Hypersensitivity</p>"},{"title":"Precautions","content":"- Cardiac arrhythmias associated with tachycardia\n- Caution in patients with cardiac history\n- May cause hypokalemia\n- May cause hyperglycemia\n- Watch for paradoxical bronchospasm (stop igit initmmediately)","content_html":"<ul>\n<li>Cardiac arrhythmias associated with tachycardia</li>\n<li>Caution in patients with cardiac history</li>\n<li>May cause hypokalemia</li>\n<li>May cause hyperglycemia</li>\n<li>Watch for paradoxical bronchospasm (stop igit initmmediately)</li>\n</ul>"},{"title":"Side effects","content":"- Headache\n- Dizziness\n- Nausea/vomiting\n- Tremors\n- Arrhythmias\n- Palpitations\n- Tachycardia\n- Muscle cramps","content_html":"<ul>\n<li>Headache</li>\n<li>Dizziness</li>\n<li>Nausea/vomiting</li>\n<li>Tremors</li>\n<li>Arrhythmias</li>\n<li>Palpitations</li>\n<li>Tachycardia</li>\n<li>Muscle cramps</li>\n</ul>"},{"title":"Dose","content":"Adult (assist): 5-10 puffs (50-10mcg) q(5-10) m(∞)\n\nPediatric (assist): < 20kg: 2- 4 puffs with MDI and spacer > 20kg: 4-8 puffs wit hMDI and spacer","content_html":"<p>Adult (assist): 5-10 puffs (50-10mcg) q(5-10) m(∞)</p>\n<p>Pediatric (assist): &lt; 20kg: 2- 4 puffs with MDI and spacer &gt; 20kg: 4-8 puffs wit hMDI and spacer</p>"},{"title":"Supplied","content":"- Solution: 2.5 mg/2.5 mL NS\n- Metered dose inhaler (MDI): 100 mcg per dose","content_html":"<ul>\n<li>Solution: 2.5 mg/2.5 mL NS</li>\n<li>Metered dose inhaler (MDI): 100 mcg per dose</li>\n</ul>"},{"title":"Mechanism","content":"Salbutamol sulfate is a sympathomimetic which is selective for B2-adrenergic receptors.\n\nIt relaxes smooth muscles of the bronchial tree and peripheral vasculature by stimulating adrenergic receptors of the sympathetic nervous system.\n\n- Onset in 5-8 min\n- Peak effects within 1-1.5 hours\n- Duration of 3-6 hours\n- 1⁄2 life of ≤ 3 hours","content_html":"<p>Salbutamol sulfate is a sympathomimetic which is selective for B2-adrenergic receptors.</p>\n<p>It relaxes smooth muscles of the bronchial tree and peripheral vasculature by stimulating adrenergic receptors of the sympathetic nervous system.</p>\n<ul>\n<li>Onset in 5-8 min</li>\n<li>Peak effects within 1-1.5 hours</li>\n<li>Duration of 3-6 hours</li>\n<li>1⁄2 life of ≤ 3 hours</li>\n</ul>"},{"title":"Notes","content":"Watch for tachycardia with administration\n\nDecreased effect in patients on beta blockers\n\nSalbutamol may precipitate angina and dyshythmias","content_html":"<p>Watch for tachycardia with administration</p>\n<p>Decreased effect in patients on beta blockers</p>\n<p>Salbutamol may precipitate angina and dyshythmias</p>"}]},{"id":"tetracaine","title":"tetracaine","body":"<h2>Generic Name</h2>\n<p>tetracaine</p>\n<h2>Trade</h2>\n<p>Pontocaine</p>\n<h2>Classification</h2>\n<p>Topical ophthalmic anesthetic</p>\n<h2>Indications</h2>\n<ul>\n<li>Short term relief from eye irritation or pain</li>\n<li>Patient comfort before eye irrigation</li>\n</ul>\n<h2>Contraindications</h2>\n<ul>\n<li>Open injury to the eye</li>\n<li>Sulfite medications</li>\n<li>Paraben medications</li>\n</ul>\n<h2>Precautions</h2>\n<p>Tetracaine is not recommended for long term use</p>\n<h2>Side effects</h2>\n<ul>\n<li>Burning or stinging sensation</li>\n<li>Blurred vision</li>\n<li>Photophobia</li>\n<li>Irritation</li>\n</ul>\n<h2>Dose</h2>\n<p>Adult: 1-2 drops/eye</p>\n<p>Pediatric: 1-2 drops/eye</p>\n<h2>Supplied</h2>\n<p>0.5% solution in various volumes</p>\n<h2>Mechanism</h2>\n<p>Reduces sodium permeability therefore increasing the action potential of the cell which inhibits the conduciton of nerve impulses from the sensory nerves.</p>\n<ul>\n<li>Onset is immediate</li>\n<li>Peak effects within 1 min</li>\n<li>Duration of 10-15 min</li>\n<li>½ life is unknown</li>\n</ul>\n<h2>Notes</h2>\n<p>Incompatible with mercury or silver salts often found in opthalmic products</p>\n","meta":{"scope":"information-only","order":1},"sections":[{"title":"Generic Name","content":"tetracaine","content_html":"<p>tetracaine</p>"},{"title":"Trade","content":"Pontocaine","content_html":"<p>Pontocaine</p>"},{"title":"Classification","content":"Topical ophthalmic anesthetic","content_html":"<p>Topical ophthalmic anesthetic</p>"},{"title":"Indications","content":"- Short term relief from eye irritation or pain\n- Patient comfort before eye irrigation","content_html":"<ul>\n<li>Short term relief from eye irritation or pain</li>\n<li>Patient comfort before eye irrigation</li>\n</ul>"},{"title":"Contraindications","content":"- Open injury to the eye\n- Sulfite medications\n- Paraben medications","content_html":"<ul>\n<li>Open injury to the eye</li>\n<li>Sulfite medications</li>\n<li>Paraben medications</li>\n</ul>"},{"title":"Precautions","content":"Tetracaine is not recommended for long term use","content_html":"<p>Tetracaine is not recommended for long term use</p>"},{"title":"Side effects","content":"- Burning or stinging sensation\n- Blurred vision\n- Photophobia\n- Irritation","content_html":"<ul>\n<li>Burning or stinging sensation</li>\n<li>Blurred vision</li>\n<li>Photophobia</li>\n<li>Irritation</li>\n</ul>"},{"title":"Dose","content":"Adult: 1-2 drops/eye\n\nPediatric: 1-2 drops/eye","content_html":"<p>Adult: 1-2 drops/eye</p>\n<p>Pediatric: 1-2 drops/eye</p>"},{"title":"Supplied","content":"0.5% solution in various volumes","content_html":"<p>0.5% solution in various volumes</p>"},{"title":"Mechanism","content":"Reduces sodium permeability therefore increasing the action potential of the cell which inhibits the conduciton of nerve impulses from the sensory nerves.\n\n- Onset is immediate\n- Peak effects within 1 min\n- Duration of 10-15 min\n- ½ life is unknown","content_html":"<p>Reduces sodium permeability therefore increasing the action potential of the cell which inhibits the conduciton of nerve impulses from the sensory nerves.</p>\n<ul>\n<li>Onset is immediate</li>\n<li>Peak effects within 1 min</li>\n<li>Duration of 10-15 min</li>\n<li>½ life is unknown</li>\n</ul>"},{"title":"Notes","content":"Incompatible with mercury or silver salts often found in opthalmic products","content_html":"<p>Incompatible with mercury or silver salts often found in opthalmic products</p>"}]}]